Has Daniel Horton received payments from drug or device companies?

Yes. Drug and device makers reported $1,906 in general payments to Daniel Horton across 121 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Daniel Horton did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Daniel Horton come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Daniel Horton

Medical · Glens Falls, NYNPI 1629619846

Payments from drug & device makers

$1,906in general payments, 2019–2025

Across 121 payments — averaging $15.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pfizer$374
Collegium Pharmaceutical, Inc.$285
Antares Pharma, Inc.$271
Scilex Pharmaceuticals Inc.$204
Stryker$153
AbbVie$141
plus $478 from 14 others

What the payments were for

Food & beverage$1,906100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pfizer	24	$374
Collegium Pharmaceutical, Inc.	40	$285
Antares Pharma, Inc.	13	$271
Scilex Pharmaceuticals Inc.	10	$204
Stryker	2	$153
AbbVie	7	$141
Nevro Corp.	4	$82
Vertex	4	$71
Jazz Pharmaceuticals Inc.	2	$39
Optinose US, Inc.	2	$36
Alk-abello, Inc	2	$35
Regeneron Healthcare Solutions, Inc.	2	$33
Kaleo, Inc.	2	$30
Intersect ENT, Inc.	1	$29
International Rehabilitative Sciences, Inc	1	$28
GSK	1	$25
AstraZeneca	1	$21
Takeda Pharmaceuticals U.S.A., Inc.	1	$21
CSL Behring	1	$15
Teva Pharmaceuticals USA, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

XPRESS ENT DILATION SYSTEM$137

How this compares

$1,906 in reported general payments places this provider in the 75th percentile of 2,395 medical providers in New York.

See all medical providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OxycontinOxycodone Hcl	171	$252,636
Xtampza ErOxycodone Myristate	78	$79,471
Oxycodone Hcl	955	$31,848
Fentanyl	122	$20,564
Morphine Sulfate ErMorphine Sulfate	226	$17,368
MovantikNaloxegol Oxalate	25	$12,654
Oxymorphone Hcl ErOxymorphone Hcl	16	$11,365
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	238	$10,106
Methadone Hcl	111	$8,110
Morphine Sulfate	80	$4,127
Hydromorphone Hcl	60	$2,649
Pregabalin	79	$1,919
Diazepam	211	$1,190
Naloxone Hcl	15	$892
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	23	$884

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er	$285	$79,47178 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,395 medical providers in New York.

Other medical in Glens Falls

Rebecca EllwoodAlbany$565K
Denisse SerranoCortlandt Manor$255K
Michele Kissous-HuntNew York$246K
Laura MaroldoNew York$126K
Carl ClarkeBrooklyn$116K
Maureen ThyneNew York$109K
Gina FriesRochester$106K
Ilse StraussSmithtown$87K
Helen AdamsNew York$87K
Hailey BrickmanNew York$82K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →